Cepheid Announces Development of Four-in-One Combination Test for SARS-CoV-2, Flu A, Flu B and RSV
SUNNYVALE, Calif., June 9, 2020 / PRNewswire/ -- Cepheid today announced the development of a next-generation test to assist global efforts in the fight against the spread of COVID-19 during the upcoming respiratory virus season. The Xpert ® Xpress SARS-CoV-2/Flu/RSV four-in-one test is expected to deliver qualitative detection of SARS-CoV-2, Flu A, Flu B and RSV from a single patient sample.
Labels
startups
(216)
funding
(56)
technology
(56)
fintech
(47)
ai
(32)
artificial intelligence
(31)
covid19
(29)
startup funding
(28)
funding alert
(27)
healthtech
(24)
acquisitions
(18)
healthcare
(18)
neobanks
(17)
startup ideas
(14)
ideas
(12)
challenger banks
(10)
ecommerce
(10)
ml
(10)
agriculture
(9)
agritech
(9)
blockchain
(9)
machine learning
(9)
post covid world
(9)
AR
(8)
IoT
(8)
augmented reality
(8)
digital banks
(8)
foodtech
(8)
founders
(8)
startup strategy
(8)
analytics
(7)
edtech
(7)
VR
(6)
coronavirus
(6)
idea
(6)
lending solutions
(6)
drones
(5)
lending
(5)
vc
(5)
venture capital
(5)
virtual reality
(5)
covid cure
(4)
finance
(4)
insurtech
(4)
mental health
(4)
statistics
(4)
unicorns
(4)
wellness
(4)
algorithm
(3)
blockchaintech
(3)
covid testing
(3)
cyber security
(3)
hyperlocal
(3)
kirana
(3)
startuptech
(3)
unicorn club
(3)
CAC
(2)
contactless technology
(2)
gig economy
(2)
meditation
(2)
robotics
(2)
shared mobility
(2)
social impact
(2)
valuation
(2)
autonomous systems
(1)
blockchain technology
(1)
bockchain
(1)
bonds
(1)
cryptotech
(1)
data analytics
(1)
data security
(1)
drug discovery
(1)
e-learining
(1)
gig workers
(1)
local mobility
(1)
messaging platform
(1)
natural medicine
(1)
prepaid cards
(1)
startupindia
(1)
treasury management
(1)
wealth management
(1)
wireless charging
(1)
working capital
(1)
Sunday, 21 June 2020
Cephied announces development of Four-in-One combination test for SARS-CoV-2, Flue A, Flue B and RSV
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment